Founded by nephrologist Alfredo Zarate, MD, BioMedical Enterprises develops medical devices aimed at difficult clinical problems, including bloodstream infections, temperature management and cancer screening. Its earlier work on hemodialysis produced a patented needle designed to reduce blood-cell damage and inflammatory-factor release, earning support from the National Institutes of Health’s commercialization program. The company’s newer devices are built around identified unmet needs and are being prepared for validation and commercialization.